Carry Life@ UF System Clinical Study

Summary

The Carry Life UF system performs peritoneal ultrafiltration by adding glucose to the low glucose strength (1.36%) peritoneal dialysis fluid which has been instilled into the peritoneal cavity prior to the connection of the device. By maintaining a stable glucose concentration in the intraperitoneal fluid during the 5-hour treatment, the ultrafiltration can be increased compared to a standard CAPD dwell.

Timeline

Start

2023-09-19

Primary completion

2025-10-24

Completion

2025-11-04

Publications

• Wilkie M, Heimburger O, de Leon C, Carlsson O, Davenport A, Fan SL, Allen J, Castellano G, Daenen K, Dick J, Kamesh L, Cornacchia F, Hegbrant J. Ultrafiltration and Sodium Removal in Steady Concentration Peritoneal Dialysis: A Prospective, Multicenter, Randomized, Crossover Study. J Am Soc Nephrol. 2026 Jun 4. doi: 10.1681/ASN.0000001152. Online ahead of print.
• Wilkie M, de Leon C, Carlsson O, Hegbrant J, Heimburger O. A clinical study of efficacy and safety of the Carry Life UF system in continuous ambulatory peritoneal dialysis patients: protocol for a prospective, multicenter, randomized, crossover study. BMC Nephrol. 2025 Apr 3;26(1):174. doi: 10.1186/s12882-025-04095-2.

Drugs

Indications